Marshall Wace North America’s Guardant Health GH Stock Holding History

Marshall Wace North America’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.88M	Sell	23,021 -510,724	-96%	-$60.7M	0.01%	648
2021 Q2	$66.3M	Buy	533,745 +457,664	+602%	+$61.6M	0.28%	75
2021 Q1	$11.6M	Sell	76,081 -657,485	-90%	-$99.4M	0.05%	366
2020 Q4	$94.5M	Buy	733,566 +497,374	+211%	+$57.2M	0.43%	46
2020 Q3	$26.4M	Sell	236,192 -467,682	-66%	-$42.8M	0.17%	154
2020 Q2	$57.1M	Buy	703,874 +435,520	+162%	+$35.1M	0.38%	70
2020 Q1	$18.7M	Buy	+268,354	New	+$20.6M	0.14%	160

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Marshall Wace North America's GH Position: Q3 2021 in Review

Marshall Wace North America reduced its Guardant Health (GH) stake by 96% in Q3 2021, selling an estimated $60.7M and leaving 23,021 shares worth $2.88M. The position accounts for 0.01% of the portfolio, ranked #648.

Marshall Wace North America first reported a position in GH in Q1 2020 and has held it in 7 quarters since. The position peaked at $94.5M in Q4 2020. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

Marshall Wace North America held 23,021 shares of Guardant Health worth $2.88M as of Q3 2021.
Marshall Wace North America sold 510,724 Guardant Health shares in Q3 2021, an estimated $60.7M.
Guardant Health made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #648 holding.
Marshall Wace North America first reported a position in Guardant Health in Q1 2020 and has held it in 7 quarters since.
Marshall Wace North America's Guardant Health position peaked at $94.5M in Q4 2020.
374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.